Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy

DS‐ALL has a higher rate of relapse and treatment‐related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long‐term remission after ALL relapse due to partial chemotherapy combined severe infection is rare.

Detalles Bibliográficos
Autores principales: Hu, Zhongbo, VanHeyst, Kristen A., Dalal, Jignesh, Hackney, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981660/
https://www.ncbi.nlm.nih.gov/pubmed/33768794
http://dx.doi.org/10.1002/ccr3.3678
_version_ 1783667558354780160
author Hu, Zhongbo
VanHeyst, Kristen A.
Dalal, Jignesh
Hackney, Lisa
author_facet Hu, Zhongbo
VanHeyst, Kristen A.
Dalal, Jignesh
Hackney, Lisa
author_sort Hu, Zhongbo
collection PubMed
description DS‐ALL has a higher rate of relapse and treatment‐related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long‐term remission after ALL relapse due to partial chemotherapy combined severe infection is rare.
format Online
Article
Text
id pubmed-7981660
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79816602021-03-24 Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy Hu, Zhongbo VanHeyst, Kristen A. Dalal, Jignesh Hackney, Lisa Clin Case Rep Case Reports DS‐ALL has a higher rate of relapse and treatment‐related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long‐term remission after ALL relapse due to partial chemotherapy combined severe infection is rare. John Wiley and Sons Inc. 2021-02-12 /pmc/articles/PMC7981660/ /pubmed/33768794 http://dx.doi.org/10.1002/ccr3.3678 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Hu, Zhongbo
VanHeyst, Kristen A.
Dalal, Jignesh
Hackney, Lisa
Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title_full Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title_fullStr Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title_full_unstemmed Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title_short Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
title_sort patient with down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial r3 chemotherapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981660/
https://www.ncbi.nlm.nih.gov/pubmed/33768794
http://dx.doi.org/10.1002/ccr3.3678
work_keys_str_mv AT huzhongbo patientwithdownsyndromeandrelapsedacutelymphoblasticleukemiawithsustainedremissiondespiteonlypartialr3chemotherapy
AT vanheystkristena patientwithdownsyndromeandrelapsedacutelymphoblasticleukemiawithsustainedremissiondespiteonlypartialr3chemotherapy
AT dalaljignesh patientwithdownsyndromeandrelapsedacutelymphoblasticleukemiawithsustainedremissiondespiteonlypartialr3chemotherapy
AT hackneylisa patientwithdownsyndromeandrelapsedacutelymphoblasticleukemiawithsustainedremissiondespiteonlypartialr3chemotherapy

Ejemplares similares